Trevi Therapeutics Aktie
14,13
USD
-0,03
USD
-0,21
%
14,13
USD
-0,04
USD
-0,25
%
Werbung
Trevi Therapeutics Aktie Analyse
| 03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
| 03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung